Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LAROTRECTINIB vs LATANOPROST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LAROTRECTINIB vs LATANOPROST: Safety Overview

Metric LAROTRECTINIB LATANOPROST
Total FAERS Reports 798 15,362
Deaths Reported 149 309
Death Rate 18.7% 2.0%
Hospitalizations 151 873
Average Patient Age 48.9 yrs 71.9 yrs
% Female Patients 51.5% 65.9%
FDA Approval Date Nov 26, 2018 Apr 14, 2025
Manufacturer Bayer HealthCare Pharmaceuticals Inc. Thea Pharma Inc.
Route ORAL OPHTHALMIC
Marketing Status Prescription Prescription